Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001140361-25-014601

Director acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Eastling Thomas Wilson · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-04-16 Exercise or conversion : show line 1 in the form +15,000 $6.93 $103,950 15,000 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-04-16 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −15,000 299,652 D
Loading xslF345X05/form4.xml…